National Health (Listed drugs in Part A or Part T of F2) Determination 2010 (Cth)
PB 94 of 2010
National Health (Listed drugs in Part A or Part T of F2) Determination 20101
National Health Act 1953
I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under subsections 85AB (1) and 85AC (1) of the National Health Act 1953.
Dated 7 October 2010
FELICITY MCNEILL
Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing
Contents
1Name of Determination 2
2Commencement 2
3Repeal 2
4Definition 2
5F2 drugs in Part A of F2 2
6F2 drugs in Part T of F2 3
Schedule 1Drugs in Part A of F2 4
Schedule 2Drugs in Part T of F2 6
Name of Determination
(1) This Determination is the National Health (Listed drugs in Part A or Part T of F2) Determination 2010.
(2) This Determination may also be cited as PB 94 of 2010.
Commencement
This Determination commences on the commencement of the National Health (Listed drugs on F1 or F2) Determination 2010.
Note 1 Section 2 of the National Health (Listed drugs on F1 or F2) Determination 2010 provides that the Determination commences on 11 October 2010.
Note 2 Subsection 85AC (5) of the Act provides that this Determination ceases to be in force on 1 January 2011.
Repeal
The following determinations are repealed:
(a) Determination under subsections 85AB (1) and 85AC (1) of the National Health Act 1953 made on 7 September 2007;
(b) Determination under subsections 85AB (1) and 85AC (1) of the National Health Act 1953 made on 5 November 2007.
Note These Determinations are also known as PB 75 of 2007 and PB 95 of 2007 respectively.
Definition
In this Determination:
Actmeans the National Health Act 1953.
F2 drugs in Part A of F2
For subsection 85AC (1) of the Act, the listed drugs on F2 mentioned in Schedule 1 are in Part A of F2.
Note The drugs on F2 have been determined by the Minister under the National Health (Listed drugs on F1 or F2) Determination 2010.
F2 drugs in Part T of F2
For subsection 85AC (1) of the Act, the listed drugs on F2 mentioned in Schedule 2 are in Part T of F2.
Note The drugs on F2 have been determined by the Minister under the National Health (Listed drugs on F1 or F2) Determination 2010.
Schedule 1 Drugs in Part A of F2
(section 5)
| Alendronic acid |
| Alendronic acid with colecalciferol |
| Aluminium hydroxide with magnesium hydroxide |
| Amisulpride |
| Aspirin |
| Azithromycin |
| Betamethasone |
| Betaxolol |
| Bicalutamide |
| Bisacodyl |
| Bisoprolol |
| Bleomycin |
| Brimonidine |
| Brinzolamide |
| Bupropion |
| Cabergoline |
| Carbomer |
| Carboplatin |
| Carvedilol |
| Cefotaxime |
| Ceftriaxone |
| Cefalotin |
| Cephazolin |
| Cisplatin |
| Clindamycin |
| Clopidogrel |
| Clozapine |
| Colchicine |
| Cromoglycic acid |
| Cyclosporin |
| Desferrioxamine |
| Dexamethasone with framycetin and gramicidin |
| Digoxin |
| Diphenoxylate with atropine |
| Doxorubicin |
| Electrolyte replacement (oral) |
| Enalapril with hydrochlorothiazide |
| Epirubicin |
| Escitalopram |
| Etoposide |
| Famciclovir |
| Flecainide |
| Fluconazole |
| Fludarabine |
| Fluorouracil |
| Flutamide |
| Fluvastatin |
| Folinic acid |
| Fosinopril with hydrochlorothiazide |
| Galantamine |
| Gemcitabine |
| Gentamicin |
| Glibenclamide |
| Glipizide |
| Glucose |
| Glyceryl trinitrate |
| Hydrocortisone |
| Hypromellose |
| Hypromellose with carbomer 980 |
| Hypromellose with dextran |
| Imipramine |
| Irinotecan |
| Iron polymaltose complex |
| Isosorbide dinitrate |
| Isotretinoin |
| Ketoprofen |
| Labetalol |
| Leflunomide |
| Levetiracetam |
| Levodopa with carbidopa |
| Levonorgestrel with ethinyloestradiol |
| Loperamide |
| Medroxyprogesterone |
| Meloxicam |
| Memantine |
| Methadone |
| Methotrexate |
| Methylprednisolone |
| Mianserin |
| Mitozantrone |
| Mometasone |
| Morphine |
| Naltrexone |
| Norethisterone |
| Norethisterone with ethinyloestradiol |
| Octreotide |
| Oestradiol |
| Ondansetron |
| Oxaliplatin |
| Oxazepam |
| Oxybutynin |
| Paclitaxel |
| Pamidronic acid |
| Paraffin |
| Perindopril with indapamide |
| Pilocarpine |
| Polyvinyl alcohol |
| Potassium chloride |
| Potassium chloride with potassium bicarbonate |
| Prednisone |
| Prochlorperazine |
| Quinine |
| Risperidone |
| Selegiline |
| Sodium chloride |
| Sodium lactate compound |
| Sorbitol with sodium citrate and sodium lauryl sulfoacetate |
| Sucralfate |
| Sulfasalazine |
| Sumatriptan |
| Thyroxine |
| Ticlopidine |
| Tinidazole |
| Topiramate |
| Triamcinolone |
| Triamcinolone with neomycin, gramicidin and nystatin |
| Valproic acid |
| Vancomycin |
| Vincristine |
| Vinorelbine |
Schedule 2 Drugs in Part T of F2
(section 6)
| Aciclovir |
| Allopurinol |
| Alprazolam |
| Amiodarone |
| Amlodipine |
| Amoxycillin |
| Amoxycillin with clavulanic acid |
| Ampicillin |
| Atenolol |
| Azathioprine |
| Baclofen |
| Bromocriptine |
| Calcitriol |
| Captopril |
| Carbamazepine |
| Cefaclor |
| Cephalexin |
| Cimetidine |
| Ciprofloxacin |
| Citalopram |
| Clarithromycin |
| Clomiphene |
| Clomipramine |
| Clonazepam |
| Codeine with paracetamol |
| Cyproterone |
| Diazepam |
| Diclofenac |
| Dicloxacillin |
| Diltiazem |
| Dothiepin |
| Doxycycline |
| Enalapril |
| Erythromycin |
| Esomeprazole |
| Famotidine |
| Felodipine |
| Flucloxacillin |
| Fluoxetine |
| Fluvoxamine |
| Fosinopril |
| Frusemide |
| Gabapentin |
| Gemfibrozil |
| Gliclazide |
| Glimepiride |
| Hydrochlorothiazide with amiloride |
| Indapamide |
| Indomethacin |
| Ipratropium |
| Isosorbide Mononitrate |
| Lactulose |
| Lamotrigine |
| Lansoprazole |
| Lercanidipine |
| Lisinopril |
| Metformin |
| Methyldopa |
| Methylphenidate |
| Metoprolol |
| Metronidazole |
| Minocycline |
| Mirtazapine |
| Moclobemide |
| Naproxen |
| Nifedipine |
| Nitrazepam |
| Nizatidine |
| Norfloxacin |
| Omeprazole |
| Pantoprazole |
| Paracetamol |
| Paroxetine |
| Perindopril |
| Phenoxymethylpenicillin |
| Pindolol |
| Piroxicam |
| Pravastatin |
| Prazosin |
| Prednisolone |
| Quinapril |
| Rabeprazole |
| Ramipril |
| Ranitidine |
| Roxithromycin |
| Salbutamol |
| Sertraline |
| Simvastatin |
| Sotalol |
| Spironolactone |
| Tamoxifen |
| Temazepam |
| Terbinafine |
| Timolol |
| Tramadol |
| Trandolapril |
| Trimethoprim |
| Trimethoprim with sulfamethoxazole |
| Verapamil |
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0